The HCPLive epilepsy page is a comprehensive resource for clinical news and insights on the seizure disorder. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for epileptic seizures, and more.
December 13th 2023
In recent conversations with experts in epilepsy, the impact of stigmatization remains high for patients and ongoing efforts by clinicians to address this issue in the clinical setting has been underscored, despite the global lack of awareness about new treatments and other resources.
November 28th 2019
Researchers Find Heart Arrhythmia Gene Mutations in SUDEP
Sudden unexpected death in epilepsy (SUDEP) is poorly understood. In research presented at the American Epilepsy Society 69th Annual Meeting in Philadelphia, there is new evidence that mutations in genes that control heart rhythm may explain some cases.
Good Results with Early Resective Surgery for Epilepsy
November 3rd 2015Surgeons are more likely than ever to consider resective procedures in infants and young children who have refractory seizure disorders. Many reports describe good outcomes in infants and young children undergoing resective surgery, but longitudinal data have been published only rarely.
Emerging Diseases: Tapeworm Brain Cysts on Rise in US
Neurologists seeing patients with seizures who are from developing countries in Latin America, sub-Saharan Africa and other countries with much poverty and poor sanitation should be on the lookout for neurocysticercosis, a condition related to exposure to tapeworms.
Medical Marijuana: $100 Mil Investment in Jamaican Weed
A Canadian company announced it would invest $100 million (US dollars) in Jamaican marijuana research and development. A Colorado company also plans to invest there. Though marijuana has long been grown in Jamaica and exported illegally, the island's government decriminalized medical use in February.
Pediatric Epilepsy Racks Up Big Bills
The year following a child's first diagnosis of epilepsy is likely to cost as much as $20,000 researchers concluded after a retrospective study of billing data for 258 patients. Jamie L. Ryan, PhD, and colleagues findings' were published in Neurology online on July 10, 2015.
Study Will Evaluate Bipolar Medication in Treating Borderline Personality Disorder
Borderline personality disorder (BPD) is challenging to diagnose and treat. As yet, there are no drugs currently licensed for BPD treatment. In fact, guidance from England's National Institute for Health and Care Excellence recommends that pharmacologic therapy not be used for patients with BPD at all. This is potentially troubling, because those patients typically experience rapid and extreme changes in mood, poor social functioning and have high rates of suicidal behavior.
Cannabis Docs Need Immunity, AMA Says
Despite assurances from the Obama administration that physicians who provide marijuana to patients for therapeutic use in states where that is legal will not face federal prosecution, the AMA is calling for a law. They want an ironclad guarantee these doctors will have legal immunity.